Stocks and Finance

VIVUS

VIVUS 5/11/2012

14:25 : Arena news boosts Orexigen, Vivus shares - BOSTON (MarketWatch) -- Shares of diet-drug developer Orexigen Therapeutics shot up 20% to $4.03 Friday in the wake of news that an advisory panel of the U.S. Food and Drug Administration has recommended approval of Arena ...
Source : marketwatch-com

VIVUS 4/10/2012

11:47 : Options Traders Extending Out to September in VIVUS (VVUS) - Former President George W. Bush said Tuesday he wishes his name wasn't so firmly attached to one of his administration's signature pieces of legislation -- the broad-based tax cuts set to expire at the end of this year.
Source : 247wallst-com

VIVUS 4/9/2012

16:58 : FDA will take 3 more months to review Vivus drug - MOUNTAIN VIEW, Calif. (AP) -- Drug developer Vivus Inc. says that regulators will take another three months to review the safety strategy on its proposed obesity drug Qnexa....
Source : usnews-com

VIVUS 3/30/2012

14:22 : Vivus ([[VVUS]] +5.3%) and Arena Pharmaceuticals ([[ARNA]] +0.3%), competi - Vivus (VVUS +5.3%) and Arena Pharmaceuticals (ARNA +0.3%), competing to win U.S. regulatory approval for weight-loss treatments, probably won't be affected by an FDA advisory panel's recommendation for heart-risk ...
Source : seekingalpha-com
06:40 : Shares of Vivus (VVUS) move up 4.2% in premarket trading as the dust still - Shares of Vivus (VVUS) move up 4.2% in premarket trading as the dust still clears from a FDA panel that had implications for weight-loss drug Qnexa. Yesterday's roller coaster ride for VVUS may have been a bit of a case of "itchy trader fingers" ...
Source : seekingalpha-com
00:31 : Vivus call 'fly in play' - VVUS - Vivus, Inc. – A large options trade on Vivus, Inc. appears to be a directional bet on the biotech company’s shares ahead of impending recommendations from an advisory panel, as well as a possible decision from FDA regulators, ...
Source : fxstreet-com

VIVUS 3/29/2012

14:23 : Shares of Vivus ([[VVUS]] +8.1%) skyrocket after sitting in negative terri - Shares of Vivus (VVUS +8.1%) skyrocket after sitting in negative territory for most of the day. Traders are locked in on the tone from an ongoing FDA panel that covers the firm's Qnexa weight-loss drug. Post your comment!
Source : seekingalpha-com

VIVUS 3/1/2012

09:21 : Vivus (VVUS) draws in more buyers after Cowen comes in with its call for ... - Vivus (VVUS) draws in more buyers after Cowen comes in with its call for a $40 trading price on shares if Qnexa lands final approval to become the first FDA-approved weight-loss drug since 1999. Shares +1.9% premarket to $22.93, up 131% YTD. ...
Source : seekingalpha-com

VIVUS 2/23/2012

14:21 : Vivus Shares Surge After FDA Panel Backs Diet Drug - Vivus shares doubled after a federal advisory panel overwhelmingly backed the weight-loss drug Qnexa, clearing the way for U.S. approval of the first prescription diet drug in more than a decade.
Source : wsj-com
08:53 : Futures Rise on Weekly Jobless Claims; Target, Vivus, H-P In Focus - Futures on the Dow Jones Industrial Average (DJIA) are indicating an opening gain of about 24 points heading into the open, as Wall Street warmly received the latest employment data. Specifically, weekly jobless ...
Source : forbes-com

VIVUS 2/22/2012

18:29 : Vivus weight-loss drug backed by FDA advisers - SAN FRANCISCO (MarketWatch) -- Vivus Inc. said late Wednesday a Food and Drug Administration advisory panel recommended 20 to 2 that the agency approve its weight-loss drug Qnexa. Shares of Vivus, which had been halted all day ...
Source : marketwatch-com
17:40 : Vivus diet drug gets FDA panel backing: reports - SAN FRANCISCO (MarketWatch) -- A panel that advises the Food and Drug Administration recommended approval of a weight-loss drug made by Vivus Inc. , according to media reports later Wednesday. The advisory panel, which the FDA is not required ...
Source : marketwatch-com
16:54 : VIVUS Scores FDA Backing For Qnexa Against Obesity (VVUS, OREX, ARNA) - Campbell is planning to put its soups in new packages, such as pouches, as part of its plan to spark growth in its namesake business. It is also adding soups with bolder flavors, including Thai and Mideast seasonings.
Source : 247wallst-com

VIVUS 2/17/2012

09:15 : FDA raises safety concerns for Vivus diet pill - WASHINGTON (AP) -- Federal health officials continue to voice safety concerns over an experimental diet pill from drugmaker Vivus Inc., which will make its second attempt to convince experts of the drugs' safety next week....
Source : usnews-com

VIVUS 2/16/2012

15:26 : Shares of Vivus ([[VVUS]] -9.1%) fall into an afternoon swoon after being ... - Shares of Vivus (VVUS -9.1%) fall into an afternoon swoon after being in positive territory earlier in the day. Chatter that the FDA might require a large cardiovascular safety study of Qnexa before approving it seems to be the culprit behind ...
Source : seekingalpha-com

VIVUS 12/22/2011

12:23 : Vivus falls 15% on drug safety study - BOSTON (MarketWatch) -- Shares of diet-drug developer Vivus Inc. fell 15% to $8.88, the day after it announced that an analysis of medical claims related to the drug compound topiramate showed that babies born to mothers who were taking the ...
Source : marketwatch-com
11:26 : Vivus Data Shows Weight Loss Drug Ingredient Associated with Oral Clefts - Vivus (VVUS) said late yesterday there was an increased association between babies born with an oral cleft in mothers who took the drug in the company’s weight loss treatment while pregnant.
Source : forbes-com

VIVUS 12/21/2011

19:25 : Vivus (VVUS) falls after releasing new safety data related to its proposed - Vivus (VVUS) falls after releasing new safety data related to its proposed diet drug Qnexa. The company's analysis found that one ingredient, which is also used in an anti-seizure drug, was associated with higher rate of cleft palates in ...
Source : seekingalpha-com

VIVUS 9/21/2011

10:14 : Add Vivus ([[VVUS]] +4.1%) to the list of companies showing a gain on ... - Add Vivus (VVUS +4.1%) to the list of companies showing a gain on speculation that demand for obesity drugs will take off following Orexigen's (OREX +52%) restart on development of Contrave. The momentum buying looks to be led by loose talk ...
Source : seekingalpha-com

VIVUS 9/15/2011

15:20 : Diet-drug makers rally on Vivus update - BOSTON (MarketWatch) -- Shares of diet-drug developers Vivus Inc. , Arena Pharmaceuticals , and Orexigen Therapeutics gained ground Thursday on news that Vivus plans to resubmit ...
Source : marketwatch-com
13:17 : Pharma News: Vivus, Transcept - Vivus (VVUS) said today it the US Food and Drug Administration has agreed to allow an early resubmission for its Qnexa obesity drug. The FDAs Endocrine and Metabolic division agreed to a plan that allows for the new drug application to be ...
Source : forbes-com

VIVUS 9/13/2011

12:58 : VIVUS ([[VVUS]] +1.6%) is up on positive results from its avanafil phase ... - VIVUS (VVUS +1.6%) is up on positive results from its avanafil phase 3 study. The companys says male diabetics receiving the drug had significant improvement in erectile function. Post your comment!
Source : seekingalpha-com
actualidad VIVUS -

VIVUS by date


Pharmaceuticals

Medical Supplies

Medical Equipment

Health Care Providers

Biotechnology

Copyright © 2009 Finaperf.com - Exchange rate - Investir - Stock Exchange - Börse - Finanças - Bolsa - Tous droits réservés
Site édité par Yanga.net - Contacts